Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)

Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)

Bibliographic Details
Main Authors: M. Brausi, F.Calais da Silva, P. Ferrari, G. Ferrari, S. Rabito
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320355506
id doaj-b8c9a07bb8a14874b76489124dcefda8
record_format Article
spelling doaj-b8c9a07bb8a14874b76489124dcefda82020-12-30T04:22:25ZengElsevierEuropean Urology Open Science2666-16832020-10-0120S137Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)M. BrausiF.Calais da SilvaP. FerrariG. FerrariS. Rabitohttp://www.sciencedirect.com/science/article/pii/S2666168320355506
collection DOAJ
language English
format Article
sources DOAJ
author M. Brausi
F.Calais da Silva
P. Ferrari
G. Ferrari
S. Rabito
spellingShingle M. Brausi
F.Calais da Silva
P. Ferrari
G. Ferrari
S. Rabito
Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
European Urology Open Science
author_facet M. Brausi
F.Calais da Silva
P. Ferrari
G. Ferrari
S. Rabito
author_sort M. Brausi
title Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
title_short Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
title_full Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
title_fullStr Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
title_full_unstemmed Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)
title_sort intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from seug (south european uro-onco group)
publisher Elsevier
series European Urology Open Science
issn 2666-1683
publishDate 2020-10-01
url http://www.sciencedirect.com/science/article/pii/S2666168320355506
work_keys_str_mv AT mbrausi intermittentandrogenblockadecanbeatherapeuticoptioninpatientswithlocallyadvancedandmetastaticprostatecancerlongtermresultsfromapooledanalysisof2prospectiverandomisedtrials94019901fromseugsoutheuropeanurooncogroup
AT fcalaisdasilva intermittentandrogenblockadecanbeatherapeuticoptioninpatientswithlocallyadvancedandmetastaticprostatecancerlongtermresultsfromapooledanalysisof2prospectiverandomisedtrials94019901fromseugsoutheuropeanurooncogroup
AT pferrari intermittentandrogenblockadecanbeatherapeuticoptioninpatientswithlocallyadvancedandmetastaticprostatecancerlongtermresultsfromapooledanalysisof2prospectiverandomisedtrials94019901fromseugsoutheuropeanurooncogroup
AT gferrari intermittentandrogenblockadecanbeatherapeuticoptioninpatientswithlocallyadvancedandmetastaticprostatecancerlongtermresultsfromapooledanalysisof2prospectiverandomisedtrials94019901fromseugsoutheuropeanurooncogroup
AT srabito intermittentandrogenblockadecanbeatherapeuticoptioninpatientswithlocallyadvancedandmetastaticprostatecancerlongtermresultsfromapooledanalysisof2prospectiverandomisedtrials94019901fromseugsoutheuropeanurooncogroup
_version_ 1724366300042493952

Similar Items